Company profile
Odyssey Health, Inc.
OTC: ODYY · Healthcare · Medical - Devices
#1166 of 1,422 Healthcare companies by revenue
EA Score
21DFH 9DQ 38GM —SS 20
v0.1 · 55/100 weight · provisional
↑ disclosure history, filing timeliness · ↓ return on assets, balance-sheet leverage
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$1.7M
Employees
2
as of 2026-08-26
Market cap
$1.0M
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02021
Net income-$1.7M-$1.7M2025
Operating income-$1.0M-$1.0M2025
Total assets$49.7k$49.7k2025
Liabilities$3.4M$3.4M2021
Equity-$7.0M-$7.0M2025
Revenue trend
FY2015 – FY2021 · USD
FY15
FY15
FY16
FY17
FY18
FY19
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Odyssey Health, Inc.’s revenue?
Odyssey Health, Inc. booked $0 in FY2021 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Aethlon Medical, Inc.42DBurzynski Research Institute, Inc.——The Cannaisseur Group, Inc.8DAvalon GloboCare Corp.35DGenix Pharmaceuticals Corporation——Pharmadrug Inc.——Neighbors
Clark →Key facts
CEOJoseph Michael Redmond
SectorHealthcare
IndustryMedical - Devices
HeadquartersLas Vegas, NV
ExchangeOTC: ODYY
Employees2
IPO date2021-01-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.